Evidence map›Paper›PMID 37762270›Full record

ArticleInternational journal of molecular sciences2023

Multimodal OCT Control for Early Histological Signs of Vulvar Lichen Sclerosus Recurrence after Systemic PDT: Pilot Study.

Arseniy Potapov, Lev Matveev, Alexander Moiseev, Elena Sedova, Maria Loginova, Maria Karabut, Irina Kuznetsova, Viktoriya Levchenko, Elena Grebenkina, Sergey Gamayunov and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Evaluation of Skin Recovery after Fractional COSovremennye tekhnologii v meditsine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Arseniy PotapovInstitute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, 603950 Nizhny Novgorod, Russia.ORCID 0000-0003-4343-2500
Lev MatveevInstitute of Applied Physics Russian Academy of Sciences, 603950 Nizhny Novgorod, Russia.ORCID 0000-0001-5736-820X
Alexander MoiseevInstitute of Applied Physics Russian Academy of Sciences, 603950 Nizhny Novgorod, Russia.
Elena SedovaNizhny Novgorod Regional Oncologic Hospital, 603126 Nizhny Novgorod, Russia.
Maria LoginovaInstitute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, 603950 Nizhny Novgorod, Russia.
Maria KarabutInstitute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, 603950 Nizhny Novgorod, Russia.
Irina KuznetsovaDepartment of Obstetrics and Gynecology, Privolzhsky Research Medical University, 603950 Nizhny Novgorod, Russia.
Viktoriya LevchenkoNizhny Novgorod Regional Oncologic Hospital, 603126 Nizhny Novgorod, Russia.
Elena GrebenkinaNizhny Novgorod Regional Oncologic Hospital, 603126 Nizhny Novgorod, Russia.
Sergey GamayunovNizhny Novgorod Regional Oncologic Hospital, 603126 Nizhny Novgorod, Russia.ORCID 0000-0002-0223-0753
Stefka Radenska-LopovokInstitute of Clinical Morphology and Digital Pathology, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.ORCID 0000-0002-4669-260X
Marina SirotkinaInstitute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, 603950 Nizhny Novgorod, Russia.
Natalia GladkovaInstitute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, 603950 Nizhny Novgorod, Russia.
Privolzhsky Research Medical University · RUNizhny Novgorod Regional Clinical Oncology Center · RUInstitute of Applied Physics · RUSechenov University · RU

Funding

Russian Science Foundation 19-75-10084
6 · The paper itself

Abstract

Photodynamic therapy (PDT) is a modern treatment for severe or treatment-resistant vulvar lichen sclerosus (VLS). The chronic and recurrent nature of VLS requires control of recurrences at an early stage. In this paper, a non-invasive multimodal optical coherence tomography (OCT) method was used to control for early histological signs of VLS recurrence after systemic PDT using Photodithazine

Indexed as

PhotochemotherapyTomography, Optical CoherenceVulvar Lichen SclerosusAdultAgedFemaleHumansMiddle AgedPilot ProjectsRecurrenceSkinhistological signs of recurrencemultimodal optical coherence tomographyOCT angiographyOCT lymphangiographystructural OCTsystemic photodynamic therapyvulva lichen sclerosus

Identifiers

PMID37762270
PMCPMC10531024
OpenAlexW4386641250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.